SeaSpine Inc.

58 articles with SeaSpine Inc.

• SeaSpine Reports Third Quarter 2020 Financial Results

  11/9/2020

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced financial results for the three-months ended September 30, 2020.

• SeaSpine to Participate in Three Upcoming Investor Conferences - Nov 04, 2020

  11/4/2020

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the Company will participate in three upcoming virtual investor conferences.

• SeaSpine Announces Publication of Results from a Cellular Bone Graft Study in The Journal of Bone and Joint Surgery (JBJS)

  11/3/2020

  SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the publication of results from a preclinical study, “Examination of the Role of Cells in Commercially Available Cellular Allografts in Spine Fusion: An in vivo animal study,” in The Journal of Bone and Joint Surgery (JBJS). JBJS is the highest regarded scientific publication

• SeaSpine to Report Third Quarter 2020 Financial Results on November 9, 2020

  10/27/2020

  SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading on Monday, November 9, 2020. Members of the Company’s management will host a corresponding conference call and webcast beginning at 1:30 pm PT / 4:30 pm ET. Individuals interested in listening to t

• SeaSpine Research to Feature at Multiple NASS Podium Presentations

  10/6/2020

  SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the following four abstracts involving its products will be presented at scientific podium presentations at the NASS (North American Spine Society) 2020 Annual Meeting, which will be held virtually. Two of the abstracts received the “Best Paper” designation. The NASS 2020 S

• SeaSpine Reports Granting of Inducement Awards - Oct 02, 2020

  10/2/2020

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has issued inducement awards to seventeen non-executive employees.

• SeaSpine Announces Limited Commercial Launch of WaveForm C 3D-Printed Interbody Implant System

  9/23/2020

  SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its WaveForm C Interbody Implant System. WaveForm C represents the first of five 3D-printed interbody devices that the Company anticipates launching by mid-2021. This first limited launch marks the one-year anniversary of the SeaSpine and restor

• SeaSpine to Participate in the Cantor Virtual Global Healthcare Conference - Sep 02, 2020

  9/2/2020

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the Company will present at the Cantor Virtual Global Healthcare Conference on Wednesday, September 16, 2020, beginning at 2:40 pm ET.

• SeaSpine will Participate in the Wells Fargo Securities Healthcare Conference

  8/27/2020

  SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will present at the Wells Fargo Securities Healthcare Conference on Thursday, September 10, 2020, beginning at 2:00 pm ET. A live and archived webcast of the event will be available from the Investor Relations page of the Company's website at investor.seaspine.com.

• SeaSpine® Announces Limited Commercial Launch of Explorer™ TO Expandable Interbody Device

  8/11/2020

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the limited commercial launch of the Explorer™ TO System.

• SeaSpine Reports Granting of Inducement Awards - Aug 07, 2020

  8/7/2020

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has issued inducement awards to eleven non-executive employees.

• SeaSpine Reports Second Quarter 2020 Financial Results

  8/4/2020

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced financial results for the three months ended June 30, 2020.

• SeaSpine to Participate in Virtual Fireside Chat at Canaccord Genuity 40th Annual Growth Conference

  8/3/2020

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the Company will participate in a virtual fireside chat at The Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13, 2020, beginning at 2:00 pm ET.

• SeaSpine to Participate in a Virtual Fireside Chat with BTIG

  5/11/2020

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the Company will participate in a virtual fireside chat with BTIG.

• SeaSpine Reports First Quarter 2020 Financial Results

  5/6/2020

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced financial results for the three-months ended March 31, 2020.

• SeaSpine to Present at the SunTrust Robinson Humphrey (STRH) Life Sciences Summit Virtual Meeting Series

  5/1/2020

  SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in the upcoming STRH Life Sciences Summit Virtual Series. SeaSpine is scheduled to participate in a fireside chat on Thursday, May 7, 2020 at 11:00am ET. A live and archived webcast of the event will be available from the Investor Relations page of

• SeaSpine Announces Time Change for its First Quarter 2020 Earnings Conference Call on May 6, 2020

  5/1/2020

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced a time change for its first quarter financial results conference call on Wednesday, May 6, 2020.

• SeaSpine to Provide Business Update and Report First Quarter 2020 Financial Results on May 6, 2020

  4/28/2020

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it will provide a business and operational update and release first quarter financial results after the close of trading on Wednesday, May 6, 2020.

• SeaSpine Provides Preliminary Results for First Quarter 2020 and COVID-19 Related Business Update

  4/6/2020

  SeaSpine Holdings Corporation announced preliminary financial results for the first quarter of 2020 and a business update on the proactive steps it is taking in response to the global COVID-19 pandemic.

• SeaSpine Reports Granting of Inducement Awards - April 03, 2020

  4/3/2020

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has issued inducement awards to nine non-executive employees.